Signature HealthCARE Wins Gold and Top Honors in McKnight’s Excellence in Technology Awards

Ads

You May Also Like

Checkpoint Therapeutics Initiates Registrational Development Programs for Anti-PD-L1 Antibody CK-301

Ongoing endometrial and colorectal cancer cohorts intended to support BLA submissionsNEW YORK, Jan. 07, ...

Aravive Reports Third Quarter 2018 Financial Results and Provides Company Updates

- Merger completed; now operating as Aravive, Inc. (Nasdaq:ARAV), a clinical-stage biopharmaceutical company advancing ...